Table 3 Characteristics of IVF treatment and outcome according to BMI^a

No of started cycles

16 (10.26%)

111 (71.15%)

29 (18.59%)

NA

Stimulation duration (in days)

10.31 ± 1.08

9.83 ± 1.48

10.83 ± 2.05

0.009^†

GnRH-a

6 (37.5%)

50 (45.04%)

12 (41.37%)

0.821^‡

GnRH-an

10 (62.5%)

61 (54.96%)

17 (58.63%)

E₂ on triggering day (pmol/ml)

6.158 ± 2.836

5.673 ± 2.769

5.244 ± 2.876

0.599^†

Total gonadotropin dose (IU)

3.134 ± 1.034

3.019 ± 0.987

3.240 ± 1.252

0.580^†

Cancelled cycles

0 (0%)

3 (1.92%)

1 (0.64%)

0.626^‡

Retrieved oocytes

6.13 ± 4.13

6.26 ± 3.36

6.25 ± 3.06

0.880^§

GQ oocytes

3.50 ± 2.22

3.97 ± 2.44

4.25 ± 2.22

0.476^§

 Top

2.38 ± 1.56

2.90 ± 1.92

2.50 ± 1.54

0.578^§

 Good

1.90 ± 1.60

2.02 ± 1.29

1.47 ± 0.61

0.306^§

 Poor

2.00

1.54 ± 0.88

1.50 ± 0.71

NA

 Bad

1.00

1.00

1.00

NA

Transferred embryos

2.13 ± 0.89

1.93 ± 1.15

2.22 ± 0.93

0.589^§

Total No of embryos

4.17 ± 1.83

3.67 ± 2.51

3.94 ± 2.01

0.706^§

Without ET

1 (6.25%)

19 (17.11%)

2 (6.89%)

0.502^‡

ET Cleavage (day2)

9 (56.25%)

58 (52.25%)

16 (55.17%)

0.502^‡

6 (37.5%)

27 (24.32%)

7 (24.13%)

ET Blastocyst stage

0 (0%)

3 (2.7%)

2 (6.89%)

Biochemical Pregnancy Rate

5 (31.25%)

45 (40.54%)

13 (44.82%)

0.298^‡

Clinical Pregnancy Rate

5 (31.25%)

43 (38.73%)

11 (37.93%)

0.770^‡

Ongoing Pregnancy Rate

5 (31.25%)

39 (35.13%)

11 (37.93%)

0.822^‡